Literature DB >> 8547013

Drug-induced Sweet's syndrome (acute febrile neutrophilic dermatosis) associated with hydralazine.

E Gilmour1, R J Chalmers, D J Rowlands.   

Abstract

We report a case of Sweet's syndrome associated with hydralazine. The association of Sweet's syndrome with hydralazine, and with the oral contraceptive, minocycline, and trimethoprim/sulphamethoxazole, has been reported previously. We suggest that a drug aetiology should be sought in cases of Sweet's syndrome.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8547013     DOI: 10.1111/j.1365-2133.1995.tb02686.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  7 in total

1.  Necrotising fasciitis by steroid-induced Sweet's syndrome: a case report.

Authors:  Jun Ho Lee; Hwan Jun Choi
Journal:  Int Wound J       Date:  2015-05-18       Impact factor: 3.315

2.  Topotecan-induced Sweet's syndrome: A case report.

Authors:  Erika L Dickson; Arvind Bakhru; May P Chan
Journal:  Gynecol Oncol Case Rep       Date:  2013-01-12

3.  Drug-induced bullous sweet syndrome with multiple autoimmune features.

Authors:  Jared J Lund; Erik J Stratman; Deepa Jose; Ling Xia; Deborah Wilson; Mohammed Moizuddin
Journal:  Autoimmune Dis       Date:  2010-08-24

Review 4.  EPONYM. Sweet syndrome.

Authors:  Mi Jin Kim; Yon Ho Choe
Journal:  Eur J Pediatr       Date:  2010-05-06       Impact factor: 3.860

Review 5.  Insights Into the Pathogenesis of Sweet's Syndrome.

Authors:  Michael S Heath; Alex G Ortega-Loayza
Journal:  Front Immunol       Date:  2019-03-12       Impact factor: 7.561

Review 6.  Sweet's syndrome--a comprehensive review of an acute febrile neutrophilic dermatosis.

Authors:  Philip R Cohen
Journal:  Orphanet J Rare Dis       Date:  2007-07-26       Impact factor: 4.123

7.  Quinupristin/dalfopristin-induced Sweet's syndrome.

Authors:  Hye Sook Choi; Hee Jin Kim; Tae Hee Lee; Sang Hoon Lee; Tae Won Lee; Chun Gyoo Ihm; Myung Jae Kim
Journal:  Korean J Intern Med       Date:  2003-09       Impact factor: 2.884

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.